RPC – radient pharmaceuticals (US:NASDAQ)
Stock Stats
News
Ridgepost Capital (RPC) had its price target lowered by Barclays PLC from $12.00 to $11.00. They now have an "overweight" rating on the stock.
P10 (NYSE:RPC) is now covered by analysts at Weiss Ratings. They set a "hold (c)" rating on the stock.
P10 (NYSE:RPC) had its price target lowered by analysts at Barclays PLC from $13.00 to $11.00. They now have an "overweight" rating on the stock.
P10 (NYSE:RPC) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
Ridgepost Capital Reports Fourth Quarter and Full Year 2025 Earnings Results
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.